Advanced filters
Blog
Reducing inequalities
Tackling health inequalities is a long-standing aim of both the UK…
News
Zolgensma (Onasemnogene abeparvovec) is now recommended as an option for treating presymptomatic…
Blog
What is spinal muscular atrophy?
Spinal muscular atrophy (SMA) is a rare muscle-wasting condition…
News
We advise that you contact your clinical team if you have any concerns.
Update from NHS England…
Blog
1. SMA is a progressive muscle wasting condition
Over time, SMA causes muscle weakness and loss…
Blog
Earlier this year, a team led by researchers at Newcastle University conducted a study to shed…
News
MDUK will call for improved multidisciplinary care across Scotland at the Cross-Party Parliamentary…
News
We were delighted to be joined in our SMA seminar by SMA researchers Dr Melissa Bowerman and Sam…
News
Risdiplam is an oral drug that increases SMN protein levels by targeting the SMN2 gene manufactured…
News
In early December, Muscular Dystrophy UK and SMA UK reported our disappointment that, despite the…